- Home
- IMMP vs PFL Comparison
IMMP vs PFL Comparison
Compare IMMP & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- PFL
- Stock Information
- Founded
- IMMP 1987
- PFL 2003
- Country
- IMMP Australia
- PFL United States
- Employees
- IMMP N/A
- PFL N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- IMMP Health Care
- PFL Finance
- Exchange
- IMMP Nasdaq
- PFL Nasdaq
- Market Cap
- IMMP 304.0M
- PFL 333.6M
- IPO Year
- IMMP N/A
- PFL N/A
- Fundamental
- Price
- IMMP $1.91
- PFL $8.49
- Analyst Decision
- IMMP Buy
- PFL
- Analyst Count
- IMMP 2
- PFL 0
- Target Price
- IMMP $8.50
- PFL N/A
- AVG Volume (30 Days)
- IMMP 72.7K
- PFL 113.7K
- Earning Date
- IMMP 03-25-2025
- PFL 01-01-0001
- Dividend Yield
- IMMP N/A
- PFL 11.53%
- EPS Growth
- IMMP N/A
- PFL N/A
- EPS
- IMMP N/A
- PFL N/A
- Revenue
- IMMP $3,019,249.00
- PFL N/A
- Revenue This Year
- IMMP N/A
- PFL N/A
- Revenue Next Year
- IMMP $20.28
- PFL N/A
- P/E Ratio
- IMMP N/A
- PFL N/A
- Revenue Growth
- IMMP 24.11
- PFL N/A
- 52 Week Low
- IMMP $1.65
- PFL $6.98
- 52 Week High
- IMMP $3.34
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- IMMP 54.87
- PFL 47.55
- Support Level
- IMMP $1.65
- PFL $8.46
- Resistance Level
- IMMP $1.88
- PFL $8.59
- Average True Range (ATR)
- IMMP 0.08
- PFL 0.05
- MACD
- IMMP 0.01
- PFL -0.01
- Stochastic Oscillator
- IMMP 89.66
- PFL 38.89
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.